Highly active disease-modifying therapy initiation patterns in multiple sclerosis patients during the Covid19 pandemic: the Royal Free London NHS Trust experience

By Dr Charmaine Yam, Neurology Clinical Fellow, Royal Free London NHS Foundation Trust


Write up

More MS Academy Medication Projects

Setting up a Complex Disease Modifying Drug (DMD) Switching Clinic
By Aoife Shields, MS Principal Pharmacist, University College London Hospitals NHS Foundation Trust
A model of care for subcutaneous Natalizumab in the community
By Sinead Jordan, MS Clinical Nurse Specialist, St Vincents's University Hospital
Time from MDT to DMT
By Michelle Meehan, MS Clinical Nurse Specialist, UHCW
Encouraging excellence, developing leaders, inspiring change

MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.